CROI 2017 Program and Information

Program and Agenda

249 B-CELL RESPONSES POST-ART INTERRUPTION IN PERSONS TREATED IN FIEBIG I Supranee Buranapraditkun 1 , Donn Colby 2 , Suwanna Pattamasavin 2 , Suteeraporn Pinyakorn 3 , Rapee Trichaviroj 4 , Nelson L. Michael 5 , Merlin L. Robb 3 , Jintanat Ananworanich 3 , Lydie Trautmann 3 , for the RV411 and RV254/SEARCH010 study groups 1 Henry M. Jackson Fndn for the Advancement of Military Med, Bethesda, MD, USA, 2 SEARCH, The Thai Red Cross AIDS Rsr Cntr, Bangkok, Thailand, 3 US Military HIV Rsr Prog, Bethesda, MD, USA, 4 Armed Forces Rsr Inst of Med Sci, Bangkok, Thailand, 5 Walter Reed Army Inst of Rsr, Silver Spring, MD, USA 250 DC FUNCTIONALITY DISTINGUISHES HIV-1 CONTROLLERSWITH NEUTRALIZING ANTIBODY BREADTH Enrique Martin-Gayo 1 , Zhengyu Ouyang 1 , Dhohyung Kim 1 , Kellie E. Kolb 2 , Bruce D. Walker 1 , Alex K Shalek 2 , Xu G. Yu 1 1 Ragon Inst of MGH, MIT and Harvard, Cambridge, MA, USA, 2 MIT Inst for Med Engineering & Sci (IMES), Cambridge, MA, USA Poster P-E1: PERSISTENT VIREMIA AND IMMUNITY ON ART Poster Hall - 4 EF 2:30 PM - 4:00 PM 277 RESIDUAL LOW-LEVEL VIREMIA ON ART NOT ASSOCIATEDWITH LOWER SYSTEMIC EXPOSURE TO ARVs Monica Gandhi 1 , Andrei Stefanescu 2 , Ronald Bosch 2 , Rajesh T. Gandhi 3 , Joshua C. Cyktor 4 , Howard Horng 1 , Joseph J. Eron 5 , John W. Mellors 4 , Deborah McMahon 4 1 Univ of California San Francisco, San Francisco, CA, USA, 2 Harvard Univ, Boston, MA, USA, 3 Massachusettes General Hosp, Boston, MA, USA, 4 Univ of Pittsburgh, Pittsburgh, PA, USA, 5 Univ of North Carolina at Chapel Hill, Chapel Hill, NC, USA 278 ANTIGP41 TITERS REFLECT RESIDUAL REPLICATION IN VIROLOGICALLY SUPPRESSED ART PATIENTS Heloise M. Delagreverie 1 , Maxime Grudé 2 , Sidonie Lambert 3 , François Raffi 4 , Catherine Leport 5 , Cécile Goujard 6 , Lorraine Plessis 7 , Christine Katlama 8 , Francis Barin 9 , Constance Delaugerre 10 1 Hôpital Saint Louis, PARIS, France, 2 INSERM, Paris, France, 3 Institut Pierre Louis d’Epidémiologie et de Santé, Paris, France, 4 CHU Hotel-Dieu Nantes, Nantes, France, 5 Hôpital Bichat, Paris, France, 6 AP-HP, Le Kremlin-Bicêtre, France, 7 INSERM, Villejuif, France, 8 Pierre and Marie Curie Univ, Paris, France, 9 INSERM, Tours, France, 10 Hôpital Saint Louis, Paris, France 279 ANTIBODY LEVELS CORRELATEWITH THE INFECTED CELL POPULATION INHIV PATIENTS ON ART Sheila Keating 1 , Christina Lalama 2 , Ronald Bosch 2 , Deborah McMahon 3 , Joshua Cyktor 3 , John Mellors 3 , Joseph J. Eron 4 , Rajesh T. Gandhi 5 , Michael P. Busch 1 , for the ACTG 5321 team 1 Blood Systems Rsr Inst, San Francisco, CA, USA, 2 Harvard Univ, Boston, MA, USA, 3 Univ of Pittsburgh, Pittsburgh, PA, USA, 4 Univ of North Carolina at Chapel Hill, Chapel Hill, NC, USA, 5 Massachusetts General Hosp and Ragon Inst, Boston, MA, USA 280 PERSISTENT IMMUNE ACTIVATION DESPITE ART: THE“DIE IS CAST”BEFORE ART INITIATION Rajesh T. Gandhi 1 , Deborah McMahon 2 , Ronald Bosch 3 , Christina Lalama 3 , Bernard Macatangay 2 , Joshua Cyktor 2 , Ann Collier 4 , Charles Rinaldo 2 , Joseph J. Eron 5 , John Mellors 2 1 Massachusetts General Hosp and Ragon Inst, Boston, MA, USA, 2 Univ of Pittsburgh, Pittsburgh, PA, USA, 3 Harvard Univ, Boston, MA, USA, 4 Univ of Washington, Seattle, WA, USA, 5 Univ of North Carolina at Chapel Hill, Chapel Hill, NC, USA

Poster Sessions • Tuesday

CROI 2017 78